In vivo regulation of nitric oxide production by tumor necrosis factor alpha and gamma interferon, but not by interleukin-4, during blood stage malaria in mice

Infection and Immunity

Volumn 64, Issue 1, 1996, Pages 44-49

  Jacobs, Philippe ^a,b   Radzioch, Danuta ^b   Stevenson, Mary M ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; MONOCLONAL ANTIBODY; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL FEATURE; HOST RESISTANCE; INFECTION PREVENTION; MALARIA; MOUSE; NONHUMAN; PLASMODIUM CHABAUDI; PRIORITY JOURNAL; SPLENOMEGALY;

EID: 0030053630     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.1.44-49.1996     Document Type: Article

References (42)

1. Ahvazi, B. C., P. Jacobs, and M. M. Stevenson. 1995. Role of macrophage-derived nitric oxide in suppression of lymphocyte proliferation during blood-stage malaria J Leukocyte Biol. 58:23-31.
2. Appelberg, R., A. G. Castro, J. Pedrosa, R. A. Silva, I. A. Orme, and P. Minoprio. 1994. Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection. Infect. Immun. 62:3962-3971
3. Barrera, L. F., I. Kramnik, E. Skamene, and D. Radzioch. 1994. Nitrite production by macrophages derived from BCG-resistant and -susceptible congenic mouse strains in response to IFN-γ and infection with BCG Immunology 82:457-464
4. Belosevic, M., D. S. Finbloom, P. H. Van der Meide, M. V. Slayter, and C. A. Nacy. 1989. Administration of monoclonal anti-IFN-γ antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major J. Immunol. 143:266-274.
5. Bogdaa, C., Y. Vodovotz, J. Paik, Q. Xie, and C. Nathan. 1994 Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages. J. Leukocyte Biol 55:227-233.
6. Boockvar, K. S., D. L. Granger, R. M. Poston, M. Maybodi, M. K. Washington, J. B. Hibbs, Jr., and R. L. Kurlander. 1994. Nitric oxide produced during marine listeriosis is protective. Infect Immun. 62:1089-1100.
7. Campbell, I. L., L. Oxbrow, and L. C. Harrison. 1991. Reduction in insulins following administration of IFN-gamma and TNF-alpha in the NOD mouse. J. Autoimmunol. 4:249-262.
8. Cot, S., P. Ringwald, B. Mulder, P. Miailhes, J. Yap-Yap, A. K. Nüssler, and W. M. C. Eling. 1994. Nitric oxide in cerebral malaria J. Infect. Dis. 169: 1417-1418.
9. Cunha, F. Q., J. Assreuy, D. W. Moss, D. Rees, L. M. C. Leal, S. Moncada, M. Carrier, C. A. O'Donnell, and F. Y. Liew. 1994 Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: role of TNF-α and IL-1-β. Immunology 81:211-215.
10. Ding, A., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407-2412.
11. Förster, E. 1994. An improved general method to generate internal standards for competitive PCR. BioTechniques, 16:18-20.
12. Gazzinelli, R., I. P. Oswald, S. Hieny, S. L. James, and A. Sher. 1992. The microbicidal activity of interferon-γ-treated macrophages against Trypanosoma cruzi involves an L-argmine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-β. Eur. J. Immunol 22:2501-2506
13. Gazzinelli, R. T., I. Eltoum, T. A. Wynn, and A. Sher. 1993. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-α and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. J. Immunol. 151:3672-3681.
14. Green, S. J., C. A. Nacy, R. D. Schreiber, D. I. Granger, R. M. Crawford, M. S. Meltzer, and A. H. Fortier. 1993. Neutralization of gamma interferon and tumor necrosis factor alpha blocks in vivo synthesis of nitrogen oxides from L-argmine and protection against Francisella tularensis infection in Mycobacterium bovis BCG-treated mice. Infect. Immun. 61:689-698.
15. Haak-Frendscho, M., J. F. Brown, Y. Iizawa, R. D. Wagner, and C. J. Czuprynski. 1992 Administration of anti-IL-4 monoclonal antibody 11B11 increases the resistance of mice to Listeria monocytogenes infection. J. Immunol. 148:3978-3985.
16. Havell, E. A. 1987. Production of tumor necrosis factor during murine listeriosis. J. Immunol 139:4225-4231
17. Hsieh, C., S. E. Macatonia, C. S. Tripp, S. E. Wolf, A. O'Garra, and K. M. Murphy. 1993. Development of Th1 CD4 + cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-549
18. Jacobs, P., D. Radzioch, and M. M. Stevenson. Nitric oxide expression in the spleen, but not in the liver, correlates with resistance to blood-stage malaria in mice. J. Immunol., in press.
19. Jacobs, P., D. Radzioch, and M. M. Stevenson. A Th1 associated increase in TNF-α expression in the spleen correlates with resistance to blood-stage malaria in mice. Submitted for publication.
20. Kramnik, I., E. Skamene, and D. Radzioch. 1993. Assessment of lymphokine profiles in activated lymphocytes by semiquantitive PCR J. Immunol. Methods 162:143-153.
21. Kumaratilake, L. M., D. A. Rathjen, P. Mack, F. Widmer, and V. Prasertsiriroj. 1995. A synthetic tumor necrosis factor-α agonist peptide enhances human polymorphonuclear leukocyte-mediated killing of Plasmodium falciparum in vitro and suppresses Plasmodium chabaudi infection in mice. J. Clin. Invest. 95:2315-2323.
22. Liew, F. Y., S. Millott, C. Parkinson, R. M. J. Palmer, and S. Moncada. 1990. Macrophage killing of Leishmania parasite in viro is mediated by nitric oxide from L-arginine. J. Immunol. 144:4794-4797.
23. Naotunne, T. D. S., N. D. Karunaweera, G. Del Giudice, M. U. Kularatne, G. E. Grau, R. Carter, and K. N. Mendis. 1991. Cytokines kill malaria parasites during infection crisis: extracellular complementary factors are essential. J. Exp. Med. 173:523-529.
24. Nathan, C., and Q. Xie. 1994. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269:13725-13728.
25. Nussler, A. K., W. M. C. Eling, and P. Kremsner. 1994 Patients with Plasmodium falciparum malaria and Plasmodium vivax malaria show increased nitrite and nitrate plasma levels. J. Infect. Dis. 169:1418-1419.
26. + T lymphocytes both contribute to acquired immunity to blood-stage Plasmodium chabaudi AS. Infect. Immun 59:51-58.
27. Rockett, K. A., M. M. Awburn, E. J. Rockett, W. B. Cowden, and I. A. Clark. 1994. Possible role of nitric oxide in malarial immunosuppression. Parasite Immunol. 16:243-249.
28. Rockett, K. A., D. Kwiatkowski, C. A. W. Bate, M. M. Awburn, E. J. Rockett, and I. A. Clark. In vitro induction of nitric oxide by an extract of Plasmodium falciparum. Submitted for publication
29. Silva, J. S., D. R. Twardzik, and S. G. Reed. 1991. Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor β (TGF-β) J Exp Med 174:539-545
30. Stevenson, M. M., and E. Ghadirian. 1989. Human recombinant tumor necrosis factor alpha protects susceptible A/J mice against lethal Plasmodium chabaudi AS infection Infect. Immun. 57:3936-3939.
31. Stevenson, M. M., J. J. Lyanga, and E. Skamene. 1982. Murine malaria: genetic control of resistance to Plasmodium chabaudi. Infect Immun. 38: 80-88.
32. Steveoson, M. M., M. Tam, M. Belosevic, P. van der Meide, and J. Podoba. 1990. Role of endogenous gamma initerferon in host response to infection with blood-stage Plasmodium chabaudi AS. Infect. Immun. 58:3225-3232.
33. Stevenson, M. M., M. Tam, S. F. Wolf, and A. Sher. 1995. IL-12 induced protection against blood-stage Plasmodium chabaudi AS requires IFN-γ and TNF-α and occurs via an NO-dependent mechanism. J. Immunol. 155:2545-2556.
34. Stevenson, M. M., and M.-F. Tam. 1993. Differential induction of helper T cell subsets during blood-stage Plasmodium chabaudi AS infection in resistant and susceptible mice Clin. Exp Immunol. 91:77-83.
35. Stevenson, M. M., and M.-F. Tam. Unpublished data.
36. Taylor-Robinson, A. W., R. S. Phillips, A. Severn, S. Moncada, and F. Y. Liew. 1993. The role of Th1 and Th2 cells in a rodent malaria infection. Science 260:1931-1934.
37. van der Meide, P. H., M. Dubbeld, K. Vijverberg, T. Kos, and H. Schellekens. 1986. The purification and characterization of rat gamma interferon by use of two monoclonal antibodies. J Gen. Virol. 67:1058-1071.
38. Vassalli P. 1992 The pathophysiology of tumor necrosis factors. Annu Rev. Immunol. 10:411-452.
39. Vodovotz, Y., C. Bogdan, J. Paik, Q. Xie, and C. Nathan. 1993. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β J. Exp. Med. 178:605-614
40. von der Weid, T., M. Kopf, G. Köhler, and J. Langhorne. 1994. The immune response to Plasmodium chabaudi malaria in interleukin-4-deficient mice Eur. J. Immunol. 24:2285-2293.
41. Wang, A. M., M. V. Doyle, and D. F. Mark. 1989. Quantitation of mRNA by the polymerase chain reaction. Proc. Natl Acad. Sci. USA 86:9717-9721
42. Wang, J. M., S. Walter, and A. Mantovani. 1990 Re-evaluation of the chemotactic activity of tumour necrosis factor for monocytes. Immunology 71:364-367.